Great Bay Bio Group is a high-tech company that develops blue-ocean biologics on a data-based platform. It has a long-standing biomedical R&D technology platform and a rich product development pipeline. The group headquarter is located in Central Hong Kong. Great Bay Bio adheres to the national strategic concept of technological innovation and development in Great Bay Area, so to gather high-quality resources such as Europe, America, Singapore and Hong Kong to build up a subversive drug development platform combined with AI technology, big data and Internet of Things technologies, and such could shorten the drug development cycle, significantly reduce development costs and expand the service market exponentially.
With the mission of “Challenging the Future, 3D Innovation”, the group focuses on blue ocean project, so to be a fast-growing company with promising business model, risk hedging mechanism and self-developed core technology. The company now have two major business parts, which are technology development platform and product development platform. The subsidiaries of the company include Dongguan Taili Bioengineering Co., Ltd. and Guangzhou Taili Biomedical Technology Co., Ltd.